MONIQUE URBINA: Open Payments
NPI 1629600952 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 59 payments from 15 companies in 2025. Trend: 2023 $982 · 2024 $1,060 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $363 |
| UCB, Inc. | 16 | $304 |
| PFIZER INC. | 8 | $142 |
| ARGENX US, INC. | 2 | $60 |
| Biogen, Inc. | 2 | $49 |
| SK Life Science, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $31 |
| Genentech USA, Inc. | 1 | $31 |
| Neurelis, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
Products named: QULIPTA, Zilbrysq, UBRELVY, NURTEC ODT, VYVGART HYTRULO, Fintepla, LEQEMBI, KISUNLA.
Industry payments across CA — which companies pay providers there.
